Clinical Trials

30 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT04919382 2026-03-12

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

56 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05903092 2026-03-12

MOZART

Phase 2 Suspended

84 enrolled

Small Cell Lung Carcinoma

NCT07468656 2026-03-12

SCLC Tarlatamab Blood Collection

Not yet recruiting

25 enrolled

Small Cell Lung Carcinoma

NCT04170946 2026-03-05

Talazoparib

Phase 1 Recruiting

24 enrolled

Phase 2 Active not recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04516070 2026-03-05

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

55 enrolled

CNSThoracic

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03223155 2026-03-04

COSINR

Phase 1 Active not recruiting

78 enrolled

Small Cell Lung Carcinoma

NCT05068232 2026-03-04

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

49 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07402343 2026-03-04

T-BRAIN

34 enrolled

CNSThoracic

Brain Neoplasms, Small Cell Lung Carcinoma

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT07219251 2026-03-03

EVLC

194 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT07434518 2026-02-25

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Recruiting

500 enrolled

Small Cell Lung Carcinoma

NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Phase 1 Suspended

50 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07149363 2026-02-17

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

65 enrolled

Phase 1/2 Active not recruiting

Small Cell Lung Carcinoma

NCT03830918 2026-02-12

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

59 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT06730685 2026-02-12

PHILUCA

Enrolling by invitation

160 enrolled

Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Sarcopenia

NCT07050472 2026-02-12

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

Completed

45 enrolled

Small Cell Lung Carcinoma

NCT05419076 2026-02-11

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

62 enrolled

CNSThoracic

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

NCT05703269 2026-02-10

HYPOGRYPHE

BreastCNSDermatologicGenitourinaryThoracic

244 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Small Cell Lung Carcinoma

NCT07398560 2026-02-10

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

47 enrolled

Phase NA Enrolling by invitation

Small Cell Lung Carcinoma

NCT07390565 2026-02-09

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

308 enrolled

Phase EARLY_PHASE1 Recruiting

Small Cell Lung Carcinoma

NCT05620342 2026-02-05

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

24 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07388875 2026-02-05

SKB264-ANLO

30 enrolled

Phase 1/2 Active not recruiting

Small Cell Lung Carcinoma

NCT05616624 2026-02-04

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

31 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07242547 2026-02-04

MERLIN

37 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms, Thoracic Neoplasms, Small Cell Lung Carcinoma

NCT07383454 2026-02-03

Lung Cancer Screening in Population Who Had Never Smoked

2,500 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07339059 2026-01-30

SG and Immunotherapy as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer

35 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07376499 2026-01-29

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

31 enrolled

Small Cell Lung Carcinoma

NCT05223647 2026-01-28

TRIPLEX

Phase 3 Terminated

239 enrolled

Neoplasms, Small Cell Lung Carcinoma

NCT07373964 2026-01-28

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

36 enrolled

Small Cell Lung Carcinoma

NCT07057791 2026-01-27

PrE0510

60 enrolled

Small Cell Lung Carcinoma

NCT07357532 2026-01-22

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

44 enrolled

Small Cell Lung Carcinoma

NCT07358676 2026-01-22

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

25 enrolled

Small Cell Lung Carcinoma

NCT06481813 2026-01-21

BREATHE

730 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03467360 2026-01-20

ICAR

Phase 1 Recruiting

27 enrolled

Small Cell Lung Carcinoma

NCT06957314 2026-01-20

A Study of Hospital-at-Home for People Receiving Tarlatamab

70 enrolled

Phase 1 Active not recruiting

Small Cell Lung Carcinoma

NCT03923270 2026-01-08

Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

25 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04199741 2026-01-07

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Phase 1/2 Recruiting

53 enrolled

Small Cell Lung Carcinoma

NCT07316309 2026-01-05

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

Completed

33 enrolled

Small Cell Lung Carcinoma

NCT00213798 2025-12-22

Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

Phase NA Completed

200 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07155200 2025-12-22

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Phase 1/2 Recruiting

42 enrolled